Literature DB >> 16478817

Clinical and histological characteristics of papillary thyroid microcarcinoma: results of a retrospective study in 243 patients.

Elio Roti1, Roberta Rossi, Giorgio Trasforini, Fiorenza Bertelli, Maria Rosaria Ambrosio, Luciano Busutti, Elizabeth N Pearce, Lewis E Braverman, Ettore C Degli Uberti.   

Abstract

CONTEXT: The recognition of thyroid microcarcinoma has increased due to the widespread use of ultrasound-guided fine-needle aspiration biopsies.
OBJECTIVE: The objective of this study was to describe histological and clinical characteristics of papillary thyroid microcarcinoma (PTMC) less than or equal to 1 cm.
DESIGN: This study was a retrospective cohort.
SETTING: This study was conducted at a university hospital endocrine clinic. PATIENTS: Over a 9-yr period, 243 consecutive patients with PTMC were studied.
RESULTS: PTMC was an incidental finding at surgery in 21.4% of the PTMC cases. There were no differences in the clinical characteristics between those with incidental PTMC and those with suspected thyroid carcinoma. None of the patients with a cancer less than 8 mm had distant metastases, whereas distant metastases were observed in patients with cancers >/= 8 mm (P </= 0.05). Disease-related mortality was not observed.
CONCLUSIONS: PTMC is prevalent in the population. Among patients with PTMC, tumor size more than 8 mm is associated with more aggressive disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16478817     DOI: 10.1210/jc.2005-2372

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  72 in total

1.  [Benign thyroid nodule or thyroid cancer?].

Authors:  D Führer; K W Schmid
Journal:  Internist (Berl)       Date:  2010-05       Impact factor: 0.743

2.  Biopsy of tiny thyroid nodules: not a question of "can we" but "should we".

Authors:  A M Saindane; P A Hudgins
Journal:  AJNR Am J Neuroradiol       Date:  2010-11-11       Impact factor: 3.825

3.  Features of papillary thyroid microcarcinoma in the presence and absence of lymphocytic thyroiditis.

Authors:  Hee Sung Kim; Yoon Jung Choi; Ji-Sup Yun
Journal:  Endocr Pathol       Date:  2010-09       Impact factor: 3.943

4.  Negative Fine-Needle Aspiration in Patients with Goiter: Should We Doubt It?

Authors:  Michal Mekel; Hayim Gilshtein; Abbas Al-Kurd; Bishara Bishara; Michael M Krausz; Herbert R Freund; Yoram Kluger; Ahmed Eid; Haggi Mazeh
Journal:  World J Surg       Date:  2016-01       Impact factor: 3.352

5.  Decision analysis of discordant thyroid nodule biopsy guideline criteria.

Authors:  Christopher R McCartney; George J Stukenborg
Journal:  J Clin Endocrinol Metab       Date:  2008-05-27       Impact factor: 5.958

6.  Successful sonography-guided fine-needle aspiration biopsy of a 1-millimeter-diameter papillary thyroid microcarcinoma.

Authors:  D W Kim; S H Kim; S J Jung
Journal:  AJNR Am J Neuroradiol       Date:  2009-11-26       Impact factor: 3.825

7.  A combined molecular-pathologic score improves risk stratification of thyroid papillary microcarcinoma.

Authors:  Leo A Niemeier; Haruko Kuffner Akatsu; Chi Song; Sally E Carty; Steven P Hodak; Linwah Yip; Robert L Ferris; George C Tseng; Raja R Seethala; Shane O Lebeau; Michael T Stang; Christopher Coyne; Jonas T Johnson; Andrew F Stewart; Yuri E Nikiforov
Journal:  Cancer       Date:  2011-08-31       Impact factor: 6.860

8.  Disease severity and radioactive iodine use for thyroid cancer.

Authors:  M R Haymart; D G Muenz; A K Stewart; J J Griggs; M Banerjee
Journal:  J Clin Endocrinol Metab       Date:  2013-01-15       Impact factor: 5.958

9.  [Surgery of thyroid carcinoma].

Authors:  H Dralle; K Lorenz; A Machens
Journal:  Chirurg       Date:  2009-11       Impact factor: 0.955

Review 10.  The Effectiveness of Radioactive Iodine Remnant Ablation for Papillary Thyroid Microcarcinoma: A Systematic Review and Meta-analysis.

Authors:  Guangfu Hu; Wei Zhu; Weige Yang; Hong Wang; Lei Shen; Hongwei Zhang
Journal:  World J Surg       Date:  2016-01       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.